Abbott Laboratories ABT
103.87 USD -0.61 (-0.58%)
Regular-session close
103.87 0.00 0.00%
After hours · Nov 19, 4:07 PM ET
103.61 Day range 105.83
81.97 52-week range 129.85
- YTD
- -17.10%
- 1 year
- -17.66%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 44.33B | 41.95B | 40.11B | 43.65B | 43.08B | |
| 25.01B | 23.24B | 22.13B | 24.51B | 24.54B | |
| 8.05B | 6.83B | 6.48B | 8.36B | 8.43B | |
| 6.52B | 13.40B | 5.72B | 6.93B | 7.07B | |
| 3.72 | 7.64 | 3.26 | 3.91 | 3.94 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 8.52B | 7.97B | 7.28B | 10.17B | 10.25B | |
| 86.71B | 81.41B | 73.21B | 74.44B | 75.20B | |
| 33.94B | 33.51B | 34.39B | 37.53B | 39.17B | |
| 12.93B | 14.13B | 14.68B | 16.77B | 18.05B | |
| 52.77B | 47.90B | 38.83B | 36.91B | 36.02B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.57B | 8.56B | 7.26B | 9.58B | 10.53B | |
| -2.42B | -2.34B | -3.13B | -1.74B | -2.01B | |
| -6.31B | -5.40B | -7.09B | -7.64B | -5.49B | |
| -2.17B | -2.21B | -2.20B | -1.78B | -1.89B | |
| 906.00M | 720.00M | -2.99B | 83.00M | 2.96B |
